Infect Chemother.  2009 Oct;41(5):298-300. 10.3947/ic.2009.41.5.298.

A Case of Secondary Syphilis with Jarisch-Herxheimer Reaction Presenting as Hypersensitivity Pneumonit

Affiliations
  • 1Division of Infectious Disease, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. heejinmd@medimail.co.kr

Abstract

Jarisch-Herxheimer reaction (JHR) is a self-limited, acute febrile hypersensitivity reaction that occurs after antibiotic therapy against spirochetes disease. When occurring in the text of syphilis therapy, the JHR begins typically 1-2 hour after the administration of penicillin and is characterized by fever, chills, myalgias, and exacerbation of skin lesions. Rarely, severe JHR can occur in the form of endocarditis, fulminant hepatitis, and hypersensitivity pneumonitis. Recently, we experienced an interesting case of JHR complicated by the hypersensitivity pneumonitis after treating secondary syphilis. Proper differential diagnosis is required to differentiate this reaction from drug-induced hypersensitivity reaction.

Keyword

Syphilis; Jarisch-Herxheimer reaction; Hypersensitivity pneumonitis

MeSH Terms

Alveolitis, Extrinsic Allergic
Chills
Diagnosis, Differential
Endocarditis
Fever
Hepatitis
Hypersensitivity
Penicillins
Skin
Spirochaetales
Syphilis
Penicillins
Syphilis

Figure

  • Figure 1 (A) Before treatment with penicillin, there is no abnormal lesion in both lungs. (B) 12 hours later, Abruptly developed ill-defined nodular and patchy air-space opacities are observed. (C) After 3 days, bilateral nodular and patch opacities are much improved.

  • Figure 2 Chest CT scan shows patchy air-space opacities and diffuse ground-glass opacities in both lungs, suggestive of hypersensitivity pneumonitis.


Reference

1. See S, Scott EK, Levin MW. Penicillin-induced Jarisch-Herxheimer reaction. Ann Pharmacother. 2005. 39:2128–2130.
Article
2. Kaplanski G, Granel B, Vaz T, Durand JM. Jarisch-Herxheimer reaction complicating the treatment of chronic Q fever endocarditis: elevated TNF-alpha and IL-6 serum levels. J Infect. 1998. 37:83–84.
Article
3. Silberstein P, Lawrence R, Pryor D, Shnier R. A case of neurosyphilis with a florid Jarisch-Herxheimer reaction. J Clin Neurosci. 2002. 9:689–690.
Article
4. Fathilah J, Choo MM. The Jarisch-Herxheimer reaction in ocular syphilis. Med J Malaysia. 2003. 58:437–439.
5. Bryceson AD. Clinical pathology of the Jarisch-Herxheimer reaction. J Infect Dis. 1976. 133:696–704.
Article
6. Jarisch A. Therapeutische versuche bei syphilis. Wien Med Wochenschr. 1985. 45:721–724.
7. Jarisch-Herxheimer reaction. Br Med J. 1967. 1:384.
8. Kim JW. A case of Jarisch-Herxheimer reaction complicated by fatal hypersensitivity pneumonitis in a patient with secondary syphilis. Korean J Dermatol. 2006. 44:1114–1118.
9. Pound MW, May DB. Proposed mechanisms and preventative options of Jarisch-Herxheimer reactions. J Clin Pharm Ther. 2005. 30:291–295.
Article
10. Beutler B, Munford RS. Tumor necrosis factor and the Jarisch-Herxheimer reaction. N Engl J Med. 1996. 335:347–348.
Article
11. David G, Perpoint T, Boibieux A, Pialat JB, Salord H, Devouassoux M, Chidiac C, Peyramond D. Secondary pulmonary syphilis: report of a likely case and literature review. Clin Infect Dis. 2006. 42:e11–e15.
Article
12. Yonemaru M, Mizuquchi Y, Kasuga I, Utsumi K, Ichinose Y, Toyama K. Hilar and mediastinal lymphadenopathy with hypersensitivity pneumonitis induced by penicillin. Chest. 1992. 102:1907–1909.
Article
13. de Hoyos A, Holness DL, Tarlo SM. Hypersensitivity pneumonitis and airways hyperreactivity induced by occupational exposure to penicillin. Chest. 1993. 103:303–304.
Article
14. Fekade D, Knox K, Hussein K, Melka A, Lalloo DG, Coxon RE, Warrell DA. Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. N Engl J Med. 1996. 335:311–315.
Article
Full Text Links
  • IC
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr